Confocal laser endoscopy for hepatobiliary pancreatic surgery

Confocal laser endoscopy for hepatobiliary pancreatic surgery - Confocal laser endoscopy for hepatobiliary pancreatic surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000028667

Enrollment

100

Registered

2017-08-15

Start date

2017-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neoplasm in heapato-biliary-panreatic system

Interventions

Intravenous injection of fluorescein (300mg) and observe bile duct by confocal laser endomicroscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1)Patients who are undergoing HPB surgery 2)patients from whom informed consent was obtained

Exclusion criteria

Exclusion criteria: Patients who have allergy for fluorecein, in poor general condition, severe diabetes, severe heart disease, severe cerebral arterial disease, severe respiratory disease, severe hypertention, pregnancy, liver cirrhosis, or phenocromocytoma.

Design outcomes

Primary

Measure	Time frame
Comparison between diagnosis of confocal lazer endomicroscopy with the pathological findings	—

Secondary

Measure	Time frame
Comparison between findings of confocal lazer endomicroscopy with pathological findings	—

Countries

Japan

Contacts

Public ContactMasaru Matsumura

Tokyo university Hepato-Biliary-Pancreatic Surgery Division

MATSUMURAM-SUR@h.u-tokyo.ac.jp0338155411

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026